Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
Marte Jonsson(Oslo University Hospital), Heidi Lyng(Oslo University Hospital), Anne Hansen Ree(University of Oslo), Harald Bull Ragnum(Oslo University Hospital), Therese Seierstad(Oslo University Hospital), Andrée Yeramian(Universitat de Lleida), Cathinka Halle(Oslo University Hospital), Xavier Matías‐Guiu(Universitat de Lleida), Trevor Clancy(Inholland University of Applied Sciences), Kjersti Flatmark(Oslo University Hospital), Kari‐Anne M. Frikstad(Oslo University Hospital), Trond Stokke
Cited by 28
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
|Annals of Oncology|2020|478
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
|The Journal of Pathology|2019|401